Video Experimental Relacionado
Updated: Apr 26, 2026
08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.2K
La conducción no celular autónoma del crecimiento tumoral apoya la heterogeneidad subclonal
Andriy Marusyk1, Doris P Tabassum2, Philipp M Altrock3
11] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA [3] Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.
Nature
|August 1, 2014
Resumen
El crecimiento tumoral implica la evolución somática y la heterogeneidad subclonal. Una subpoblación celular menor puede impulsar la expansión tumoral, pero puede ser superada por la competencia, lo que lleva al colapso, mientras que las interacciones estabilizan la heterogeneidad.
Área de la Ciencia:
- Oncología Oncología.
- Biología evolutiva Biología evolutiva.
- Biología Matemática Biología Matemática.
Sus antecedentes:
- Los cánceres se desarrollan a través de la evolución somática, lo que lleva a una heterogeneidad subclonal significativa dentro de los tumores.
- Los mecanismos que impulsan la coexistencia de subclones y su impacto biológico no se comprenden bien.
Objetivo del estudio:
- Investigar los efectos de la heterogeneidad subclonal en los fenotipos tumorales y la competencia de clones utilizando un modelo de xenotransplante de ratón.
- Identificar las reglas que rigen la generación de heterogeneidad clonal intra-tumoral a través del modelado matemático.
Principales métodos:
- Utilizó un modelo de xenotransplante de ratón para estudiar la dinámica del crecimiento tumoral.
- Desarrolló un marco de modelado matemático para analizar las interacciones clonales y la heterogeneidad.
Principales resultados:
- El crecimiento tumoral puede ser impulsado por una subpoblación menor que supera las restricciones ambientales, mejorando la proliferación general.
- Esta subpoblación de conducción puede ser superada por clones de crecimiento más rápido, lo que lleva al colapso del tumor.
- Se encontró que el crecimiento no celular autónomo y la interferencia clonal estabilizan la heterogeneidad subclonal.
Conclusiones:
- La heterogeneidad subclonal juega un papel crítico en la progresión tumoral y la dinámica competitiva.
- Las interacciones interclonales, estabilizadas por el crecimiento no celular autónomo y la interferencia clonal, pueden conducir a la aparición de nuevos rasgos fenotípicos.
Videos de Conceptos Relacionados
02:40Cancer Stem Cells and Tumor Maintenance
4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
02:40Cancer Stem Cells and Tumor Maintenance
2.0K
2.0K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:18Cancer
51.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.4K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K